TipRanks
Citius Pharmaceuticals (DE:47N0)
FRANKFURT:47N0
Germany Market
47N0
Citius Pharmaceuticals
RESEARCH TOOLSreports

Citius Pharmaceuticals (47N0) Income Statement

0 Followers

Citius Pharmaceuticals Income Statement

Last quarter (Q3 2026), Citius Pharmaceuticals's total revenue was $1.49M, an increase of Infinity% from the same quarter last year. In Q3, Citius Pharmaceuticals's net income was $-8.86M. See Citius Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Dec 23Sep 22Sep 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -214.25K$ -209.61K$ 0.00$ 0.00$ -164.87K
Operating Expenses
$ 38.31M$ 42.00M$ 36.73M$ 33.32M$ 23.37M
Depreciation and Amortization
$ 214.25K$ 209.61K$ 194.32K$ 179.68K$ 164.87K
EBITDA
$ -38.20M$ -38.64M$ -36.54M$ -33.14M$ -23.37M
Operating Income
$ -38.53M$ -42.00M$ -36.73M$ -33.32M$ -23.53M
Other Income/Expenses
$ -157.70K$ 3.15M$ 4.77M$ 251.40K$ 477.46K
Pretax Income
$ -38.68M$ -38.85M$ -31.97M$ -33.06M$ -23.05M
Net Income
$ -37.43M$ -39.14M$ -32.54M$ -33.64M$ -23.05M
Per Share Metrics
Basic EPS
$ -3.38$ -5.97$ -5.57$ -5.75$ -5.64
Diluted EPS
$ -3.38$ -5.97$ -5.57$ -5.75$ -5.64
Weighted Average Shares Outstanding
 11.07M 11.59M 6.05M 5.84M 4.34M
Weighted Average Shares Outstanding (Diluted)
 11.07M 11.59M 6.05M 5.84M 4.34M
Currency in USD

Citius Pharmaceuticals Earnings and Revenue History